2020
DOI: 10.1007/s00595-020-02073-9
|View full text |Cite
|
Sign up to set email alerts
|

A phase II study of ramelteon for the prevention of postoperative delirium in elderly patients undergoing gastrectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…Hokuto et al ( 2020) reported that ramelt-eon, an agonist of the melatonin receptor, reduces the risk of POD after hepatectomy. Honda et al (2020) also reported that ramelteon is feasible for preventing POD in elderly patients after gastrectomy. In the future, such drugs may be used to prevent delirium in elderly patients after hepatectomy.…”
Section: Discussionmentioning
confidence: 94%
“…Hokuto et al ( 2020) reported that ramelt-eon, an agonist of the melatonin receptor, reduces the risk of POD after hepatectomy. Honda et al (2020) also reported that ramelteon is feasible for preventing POD in elderly patients after gastrectomy. In the future, such drugs may be used to prevent delirium in elderly patients after hepatectomy.…”
Section: Discussionmentioning
confidence: 94%
“…Ramelteon, the only melatonin analog included in this meta-analysis, has a 6-fold higher affinity for melatonin 1 receptors and a 3-fold higher affinity for melatonin 2 receptors ( 44 ); ramelteon's higher affinity for melatonin receptors may contribute to its favorable benefits in delirium prevention, and previous RCTs reported that ramelteon can reduce POD after non-cardiac surgery in elderly patients ( 45 , 46 ). However, in this meta-analysis, results from an RCT and an observational study showed no evidence of a preventive effect of ramelteon 8 mg on POD in adults who underwent cardiac surgery.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, in a recent clinical study, ramelteon was found to be effective for the prevention of delirium in elderly patients undergoing gastrectomy. 2 Therefore, ramelteon represents an interesting synthetic target. However, ramelteon’s molecular structure consisting of a tricyclic 1,6,7,8-tetrahydro-2 H -indeno[5,4- b ]furan core containing a chiral substituent suggests that its concise and efficient asymmetric synthesis might be challenging.…”
mentioning
confidence: 99%
“…The ramelteon market value in 2019 accounted for $161 million (USD), which makes it a valuable drug in the category of medications for the treatment of sleeping disorders. Moreover, in a recent clinical study, ramelteon was found to be effective for the prevention of delirium in elderly patients undergoing gastrectomy . Therefore, ramelteon represents an interesting synthetic target.…”
mentioning
confidence: 99%